Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04766684Phase 4Completed
A Phase 4 trial of lidocaine 10% oropharyngeal spray in clubfoot (CTEV), sponsored by Vanderbilt University Medical Center. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04766684.